These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38019054)

  • 1. Change in Biologic Class Promotes Endoscopic Remission Following Endoscopic Postoperative Crohn's Disease Recurrence.
    Bachour SP; Shah RS; Joseph A; Syed H; Ali AH; Rieder F; Barnes EL; Axelrad J; Holubar SD; Regueiro M; Cohen BL; Click BH
    J Clin Gastroenterol; 2023 Nov; ():. PubMed ID: 38019054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Initiation of Antitumor Necrosis Factor Therapy Reduces Postoperative Recurrence of Crohn's Disease Following Ileocecal Resection.
    Axelrad JE; Li T; Bachour SP; Nakamura TI; Shah R; Sachs MC; Chang S; Hudesman DP; Holubar SD; Lightner AL; Barnes EL; Cohen BL; Rieder F; Esen E; Remzi F; Regueiro M; Click B
    Inflamm Bowel Dis; 2023 Jun; 29(6):888-897. PubMed ID: 35905032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative Crohn's Disease Recurrence Risk and Optimal Biologic Timing After Temporary Diversion Following Ileocolic Resection.
    Joseph A; Bachour SP; Shah R; El Halabi J; Syed H; Lyu R; Cohen B; Rieder F; Achkar JP; Philpott J; Qazi T; Hull T; Lipman J; Wexner S; Holubar SD; Regueiro M; Click B
    Inflamm Bowel Dis; 2024 Jun; ():. PubMed ID: 38842693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential risk of disease progression between isolated anastomotic ulcers and mild ileal recurrence after ileocolonic resection in patients with Crohn's disease.
    Ollech JE; Aharoni-Golan M; Weisshof R; Normatov I; Sapp AR; Kalakonda A; Israel A; Glick LR; Karrison T; Dalal SR; Sakuraba A; Cohen RD; Rubin DT; Pekow J
    Gastrointest Endosc; 2019 Aug; 90(2):269-275. PubMed ID: 30738034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra-abdominal septic complications after ileocolic resection increases risk for endoscopic and surgical postoperative Crohn's disease recurrence.
    Bachour SP; Shah RS; Rieder F; Qazi T; Achkar JP; Philpott J; Lashner B; Holubar SD; Lightner AL; Barnes EL; Axelrad J; Regueiro M; Click B; Cohen BL
    J Crohns Colitis; 2022 Nov; 16(11):1696-1705. PubMed ID: 35705188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rates of Postoperative Recurrence of Crohn's Disease and Effects of Immunosuppressive and Biologic Therapies.
    Rivière P; Vermeire S; Irles-Depe M; Van Assche G; Rutgeerts P; Denost Q; Wolthuis A; D'Hoore A; Laharie D; Ferrante M
    Clin Gastroenterol Hepatol; 2021 Apr; 19(4):713-720.e1. PubMed ID: 32272248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Value of the Modified Rutgeerts Score for Long-Term Outcomes After Primary Ileocecal Resection in Crohn's Disease.
    Bak MTJ; Ten Bokkel Huinink S; Erler NS; Bodelier AGL; Dijkstra G; Romberg-Camps M; de Boer NKH; Hoentjen F; Stassen LPS; van der Meulen-de Jong AE; West RL; van Ruler O; van der Woude CJ; de Vries AC;
    Am J Gastroenterol; 2024 Feb; 119(2):306-312. PubMed ID: 37737675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colonoscopy-guided therapy for the prevention of post-operative recurrence of Crohn's disease.
    Candia R; Bravo-Soto GA; Monrroy H; Hernandez C; Nguyen GC
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD012328. PubMed ID: 32746500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-World Surgical and Endoscopic Recurrence Based on Risk Profiles and Prophylaxis Utilization in Postoperative Crohn's Disease.
    Shah RS; Bachour S; Joseph A; Xiao H; Lyu R; Syed H; Li T; Pothula S; Vinaithirthan V; Ali AH; Contreras S; Hu JH; Barnes EL; Axelrad JE; Holubar SD; Regueiro M; Cohen BL; Click BH
    Clin Gastroenterol Hepatol; 2024 Apr; 22(4):847-857.e12. PubMed ID: 37879523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mild neoterminal ileal post-operative recurrence of Crohn's disease conveys higher risk for severe endoscopic disease progression than isolated anastomotic lesions.
    Bachour SP; Shah RS; Lyu R; Rieder F; Qazi T; Lashner B; Achkar JP; Philpott J; Barnes EL; Axelrad J; Holubar SD; Lightner AL; Regueiro M; Cohen BL; Click BH
    Aliment Pharmacol Ther; 2022 May; 55(9):1139-1150. PubMed ID: 35285534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histologic Activity from Neoterminal Ileal Biopsies in Patients with Crohn's Disease in Endoscopic Remission is Associated with Postoperative Recurrence.
    Shah RS; Hu JH; Bachour S; Joseph A; Syed H; Yang Q; Ali AH; Li T; Contreras S; Pothula S; Vinaithirthan V; Regueiro M; Axelrad J; Barnes EL; Cohen BL; Click BH
    Am J Gastroenterol; 2024 Jul; ():. PubMed ID: 39007494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. American Gastroenterological Association-Proposed Fecal Calprotectin Cutoff of 50 ug/g is Associated With Endoscopic Recurrence in a Real-World Cohort of Patients With Crohn's Disease Post-ileocolic Resection.
    Li T; Shah R; Click B; Cohen BL; Barnes E; Joseph A; Bachour S; Hu J; Contreras S; Li E; Axelrad J
    Crohns Colitis 360; 2024 Jan; 6(1):otae016. PubMed ID: 38525200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adalimumab in prevention of postoperative recurrence of Crohn's disease in high-risk patients.
    Aguas M; Bastida G; Cerrillo E; Beltrán B; Iborra M; Sánchez-Montes C; Muñoz F; Barrio J; Riestra S; Nos P
    World J Gastroenterol; 2012 Aug; 18(32):4391-8. PubMed ID: 22969204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of simultaneous treatment with two biologic medications in refractory Crohn's disease.
    Yang E; Panaccione N; Whitmire N; Dulai PS; Vande Casteele N; Singh S; Boland BS; Collins A; Sandborn WJ; Panaccione R; Battat R
    Aliment Pharmacol Ther; 2020 Jun; 51(11):1031-1038. PubMed ID: 32329532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Withdrawal of immunosuppressant or biologic therapy for patients with quiescent Crohn's disease.
    Boyapati RK; Torres J; Palmela C; Parker CE; Silverberg OM; Upadhyaya SD; Nguyen TM; Colombel JF
    Cochrane Database Syst Rev; 2018 May; 5(5):CD012540. PubMed ID: 29756637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Top-down Versus Step-up Strategies to Prevent Postoperative Recurrence in Crohn's Disease.
    Buisson A; Blanco L; Manlay L; Reymond M; Dapoigny M; Rouquette O; Dubois A; Pereira B
    Inflamm Bowel Dis; 2023 Feb; 29(2):185-194. PubMed ID: 35389489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopic Postoperative Recurrence in Crohn's Disease After Curative Ileocecal Resection with Early Prophylaxis by Anti-TNF, Vedolizumab or Ustekinumab: A Real-World Multicentre European Study.
    Yanai H; Kagramanova A; Knyazev O; Sabino J; Haenen S; Mantzaris GJ; Mountaki K; Armuzzi A; Pugliese D; Furfaro F; Fiorino G; Drobne D; Kurent T; Yassin S; Maharshak N; Castiglione F; de Sire R; Nardone OM; Farkas K; Molnar T; Krznaric Z; Brinar M; Chashkova E; Livne Margolin M; Kopylov U; Bezzio C; Bar-Gil Shitrit A; Lukas M; Chaparro M; Truyens M; Nancey S; Lobaton T; Gisbert JP; Saibeni S; Bacsúr P; Bossuyt P; Schulberg J; Hoentjen F; Viganò C; Palermo A; Torres J; Revés J; Karmiris K; Velegraki M; Savarino E; Markopoulos P; Tsironi E; Ellul P; Calviño Suárez C; Weisshof R; Ben-Hur D; Naftali T; Eriksson C; Koutroubakis IE; Foteinogiannopoulou K; Limdi JK; Liu E; Surís G; Calabrese E; Zorzi F; Filip R; Ribaldone DG; Snir Y; Goren I; Banai-Eran H; Broytman Y; Amir Barak H; Avni-Biron I; Ollech JE; Dotan I; Aharoni Golan M
    J Crohns Colitis; 2022 Dec; 16(12):1882-1892. PubMed ID: 35895074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of early endoscopic lesions on the clinical course of patients following ileocolonic resection for Crohn's disease: A 5-year prospective cohort study.
    Yamamoto T; Bamba T; Umegae S; Matsumoto K
    United European Gastroenterol J; 2013 Aug; 1(4):294-8. PubMed ID: 24917974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of surgery rates in biologic-naïve patients with Crohn's disease treated with vedolizumab or ustekinumab: findings from SOJOURN.
    Vu M; Ghosh S; Umashankar K; Weber L; Landis C; Candela N; Chastek B
    BMC Gastroenterol; 2023 Mar; 23(1):87. PubMed ID: 36966279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Use of Vedolizumab in Preventing Postoperative Recurrence of Crohn's Disease.
    Yamada A; Komaki Y; Patel N; Komaki F; Pekow J; Dalal S; Cohen RD; Cannon L; Umanskiy K; Smith R; Hurst R; Hyman N; Rubin DT; Sakuraba A
    Inflamm Bowel Dis; 2018 Feb; 24(3):502-509. PubMed ID: 29462385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.